Integra LifeSciences Holdings Corporation (IART)
After hours:
| Previous close | 56.84 |
| Open | 57.35 |
| Bid | 58.74 x 1100 |
| Ask | 93.54 x 800 |
| Day's range | 57.00 - 59.22 |
| 52-week range | 40.67 - 68.29 |
| Volume | |
| Avg. volume | 472,445 |
| Market cap | 4.863B |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | 27.60 |
| EPS (TTM) | 2.11 |
| Earnings date | 22 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 58.40 |
- Zacks
Why Integra (IART) Could Beat Earnings Estimates Again
Integra (IART) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- GlobeNewswire
Integra LifeSciences Reports Select Preliminary Fourth Quarter and Full-Year 2022 Financials
Fourth Quarter 2022 Fourth quarter 2022 revenue is expected to be in a range of $397 million to $398 million, representing a decrease of approximately 2% on a reported basis and an increase of approximately 3% on an organic basis compared to 2021. Fourth quarter 2022 adjusted earnings per diluted share is expected to be above the high end of the Company’s October guidance range. Full-Year 2022 Full-year 2022 revenue is expected to be in a range of $1,557 million to $1,558 million, representing a
- Zacks
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
